{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:56:32Z","timestamp":1791474992177,"version":"4.3.4"},"reference-count":40,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CVP"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Vascular calcification (VC) is highly prevalent in Chronic Kidney Disease (CKD) patients,\nprogresses gradually with deterioration of kidney function and is a strong, independent predictor of\ncardiovascular (CV) mortality. Matrix Gla Protein (MGP), the most potent inhibitor of VC, requires\nvitamin K as a co-factor to become biologically active. Accumulating epidemiological data have associated\nvitamin K depletion with VC progression and CV outcomes. CKD patients are characterized by\npoor vitamin K status and at the same time, pronounced CV calcification. In early and advanced CKD,\nincluding end-stage kidney disease, exogenous supplementation of vitamin K (especially with menaquinone\n7, its most bioavailable form) might decrease the inactive form of MGP (dephosphorylated, uncarboxylated\nMGP) and probably retard the progression or even reverse VC. Here, we focus and discuss\nthe interventional human studies of vitamin K supplementation in CKD patients and suggest future directions\nin this area of interest.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570161120666220209145341","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T04:59:33Z","timestamp":1644469173000},"page":"121-126","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Vitamin K Supplementation in Chronic Kidney Disease Patients: Where is\nthe Evidence?"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9423-649X","authenticated-orcid":true,"given":"Stefanos","family":"Roumeliotis","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, 1st Department of Internal Medicine, AHEPA Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7564-2724","authenticated-orcid":true,"given":"Vassilios","family":"Liakopoulos","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, 1st Department of Internal Medicine, AHEPA Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7867-6957","authenticated-orcid":true,"given":"Leon J.","family":"Schurgers","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Cardiovascular Research Institute\nMaastricht, Maastricht University Medical Centre, 6200 MD Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1681\/ASN.2004030203","volume":"16","author":"Foley R.N.","year":"2005","unstructured":"Foley R.N.; Murray A.M.; Li S.; Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005,16(2),489-495","journal-title":"J Am Soc Nephrol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1046\/j.1523-1755.2003.00838.x","volume":"63","author":"Manjunath G.","year":"2003","unstructured":"Manjunath G.; Tighiouart H.; Coresh J.; Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 2003,63(3),1121-1129","journal-title":"Kidney Int"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/ki.2008.458","volume":"74","author":"Schlieper G.","year":"2008","unstructured":"Schlieper G.; Kr\u00fcger T.; Djuric Z.; Vascular access calcification predicts mortality in hemodialysis patients. Kidney Int 2008,74(12),1582-1587","journal-title":"Kidney Int"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/bs.acc.2020.02.004","volume":"98","author":"Roumeliotis S.","year":"2020","unstructured":"Roumeliotis S.; Roumeliotis A.; Dounousi E.; Eleftheriadis T.; Liakopoulos V.; Biomarkers of vascular calcification in serum. Adv Clin Chem 2020,98,91-147","journal-title":"Adv Clin Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1525-139X.2007.00257.x","volume":"20","author":"Schlieper G.","year":"2007","unstructured":"Schlieper G.; Westenfeld R.; Brandenburg V.; Ketteler M.; Inhibitors of calcification in blood and urine. Semin Dial 2007,20(2),113-121","journal-title":"Semin Dial"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/386078a0","volume":"386","author":"Luo G.","year":"1997","unstructured":"Luo G.; Ducy P.; McKee M.D.; Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997,386(6620),78-81","journal-title":"Nature"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"E6035","DOI":"10.3390\/ijms21176035","volume":"21","author":"Roumeliotis S.","year":"2020","unstructured":"Roumeliotis S.; Roumeliotis A.; Stamou A.; The association of dp-ucMGP with cardiovascular morbidity and decreased renal function in diabetic chronic kidney disease. Int J Mol Sci 2020,21(17),E6035","journal-title":"Int J Mol Sci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jdiacomp.2017.06.012","volume":"31","author":"Roumeliotis S.","year":"2017","unstructured":"Roumeliotis S.; Roumeliotis A.; Panagoutsos S.; Matrix Gla protein T-138C polymorphism is associated with carotid intima media thickness and predicts mortality in patients with diabetic nephropathy. J Diabetes Complications 2017,31(10),1527-1532","journal-title":"J Diabetes Complications"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"E628","DOI":"10.3390\/ijms20030628","volume":"20","author":"Roumeliotis S.","year":"2019","unstructured":"Roumeliotis S.; Dounousi E.; Eleftheriadis T.; Liakopoulos V.; Association of the inactive circulating matrix GLA protein with vitamin K intake, calcification, mortality, and cardiovascular disease: A review. Int J Mol Sci 2019,20(3),E628","journal-title":"Int J Mol Sci"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1681\/ASN.2010040339","volume":"22","author":"Schlieper G.","year":"2011","unstructured":"Schlieper G.; Westenfeld R.; Kr\u00fcger T.; Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. J Am Soc Nephrol 2011,22(2),387-395","journal-title":"J Am Soc Nephrol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1471-2369-15-145","volume":"15","author":"Delanaye P.","year":"2014","unstructured":"Delanaye P.; Krzesinski J.M.; Warling X.; Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients. BMC Nephrol 2014,15,145","journal-title":"BMC Nephrol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1093\/ajh\/hpy079","volume":"31","author":"Puzantian H.","year":"2018","unstructured":"Puzantian H.; Akers S.R.; Oldland G.; Circulating dephospho-uncarboxylated matrix Gla-protein is associated with kidney dysfunction and arterial stiffness. Am J Hypertens 2018,31(9),988-994","journal-title":"Am J Hypertens"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000453368","volume":"135","author":"Thamratnopkoon S.","year":"2017","unstructured":"Thamratnopkoon S.; Susantitaphong P.; Tumkosit M.; Correlations of plasma desphosphorylated uncarboxylated matrix Gla protein with vascular calcification and vascular stiffness in chronic kidney disease. Nephron 2017,135(3),167-172","journal-title":"Nephron"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/bjh.13828","volume":"174","author":"Card D.J.","year":"2016","unstructured":"Card D.J.; Shearer M.J.; Schurgers L.J.; Gomez K.; Harrington D.J.; What\u2019s in a name? The pharmacy of vitamin K. Br J Haematol 2016,174(6),989-990","journal-title":"Br J Haematol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1093\/jn\/134.11.3100","volume":"134","author":"Geleijnse J.M.","year":"2004","unstructured":"Geleijnse J.M.; Vermeer C.; Grobbee D.E.; Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: The Rotterdam Study. J Nutr 2004,134(11),3100-3105","journal-title":"J Nutr"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"E1334","DOI":"10.3390\/nu9121334","volume":"9","author":"Riphagen I.J.","year":"2017","unstructured":"Riphagen I.J.; Keyzer C.A.; Drummen N.E.A.; Prevalence and effects of functional vitamin K insufficiency: The PREVEND study. Nutrients 2017,9(12),E1334","journal-title":"Nutrients"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.clnu.2014.03.011","volume":"34","author":"Cheung C.L.","year":"2015","unstructured":"Cheung C.L.; Sahni S.; Cheung B.M.; Sing C.W.; Wong I.C.; Vitamin K intake and mortality in people with chronic kidney disease from NHANES III. Clin Nutr 2015,34(2),235-240","journal-title":"Clin Nutr"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2174\/1570161118666200320111745","volume":"19","author":"Roumeliotis S.","year":"2021","unstructured":"Roumeliotis S.; Roumeliotis A.; Dounousi E.; Eleftheriadis T.; Liakopoulos V.; Vitamin K for the treatment of cardiovascular disease in end-stage renal disease patients: Is there hope? Curr Vasc Pharmacol 2021,19(1),77-90","journal-title":"Curr Vasc Pharmacol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1182\/blood-2006-07-035345","volume":"109","author":"Schurgers L.J.","year":"2007","unstructured":"Schurgers L.J.; Spronk H.M.; Soute B.A.; Schiffers P.M.; DeMey J.G.; Vermeer C.; Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 2007,109(7),2823-2831","journal-title":"Blood"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/ki.2013.530","volume":"86","author":"Kaesler N.","year":"2014","unstructured":"Kaesler N.; Magdeleyns E.; Herfs M.; Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation. Kidney Int 2014,86(2),286-293","journal-title":"Kidney Int"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1159\/000075344","volume":"40","author":"Spronk H.M.","year":"2003","unstructured":"Spronk H.M.; Soute B.A.; Schurgers L.J.; Thijssen H.H.; De Mey J.G.; Vermeer C.; Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. J Vasc Res 2003,40(6),531-537","journal-title":"J Vasc Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"6991","DOI":"10.3390\/nu7085318","volume":"7","author":"Scheiber D.","year":"2015","unstructured":"Scheiber D.; Veulemans V.; Horn P.; High-dose menaquinone-7 supplementation reduces cardiovascular calcification in a murine model of extraosseous calcification. Nutrients 2015,7(8),6991-7011","journal-title":"Nutrients"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1053\/j.ajkd.2011.10.041","volume":"59","author":"Westenfeld R.","year":"2012","unstructured":"Westenfeld R.; Krueger T.; Schlieper G.; Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: A randomized trial. Am J Kidney Dis 2012,59(2),186-195","journal-title":"Am J Kidney Dis"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1093\/ndt\/gft464","volume":"29","author":"Caluw\u00e9 R.","year":"2014","unstructured":"Caluw\u00e9 R.; Vandecasteele S.; Van Vlem B.; Vermeer C.; De Vriese A.S.; Vitamin K2 supplementation in haemodialysis patients: A randomized dose-finding study. Nephrol Dial Transplant 2014,29(7),1385-1390","journal-title":"Nephrol Dial Transplant"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12882-017-0609-3","volume":"18","author":"Aoun M.","year":"2017","unstructured":"Aoun M.; Makki M.; Azar H.; Matta H.; Chelala D.N.; High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: Risk factors and response to vitamin K2, A pre-post intervention clinical trial. BMC Nephrol 2017,18(1),191","journal-title":"BMC Nephrol"},{"key":"ref=26","first-page":"334","volume":"75","author":"Kazzi N.J.","year":"1990","unstructured":"Kazzi N.J.; Ilagan N.B.; Liang K-C.; Kazzi G.M.; Grietsell L.A.; Brans Y.W.; Placental transfer of vitamin K1 in preterm pregnancy. Obstet Gynecol 1990,75(3 Pt 1),334-337","journal-title":"Obstet Gynecol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"631","DOI":"10.20452\/pamw.3041","volume":"125","author":"Kurnatowska I.","year":"2015","unstructured":"Kurnatowska I.; Grzelak P.; Masajtis-Zagajewska A.; Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3-5. Pol Arch Med Wewn 2015,125(9),631-640","journal-title":"Pol Arch Med Wewn"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jash.2017.07.001","volume":"11","author":"Mansour A.G.","year":"2017","unstructured":"Mansour A.G.; Hariri E.; Daaboul Y.; Vitamin K2 supplementation and arterial stiffness among renal transplant recipients-a single-arm, single-center clinical trial. J Am Soc Hypertens 2017,11(9),589-597","journal-title":"J Am Soc Hypertens"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1681\/ASN.2020020225","volume":"31","author":"Witham M.D.","year":"2020","unstructured":"Witham M.D.; Lees J.S.; White M.; Vitamin K supplementation to improve vascular stiffness in CKD: The K4Kidneys randomized controlled trial. J Am Soc Nephrol 2020,31(10),2434-2445","journal-title":"J Am Soc Nephrol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1160\/TH14-08-0675","volume":"113","author":"Knapen M.H.","year":"2015","unstructured":"Knapen M.H.; Braam L.A.; Drummen N.E.; Bekers O.; Hoeks A.P.; Vermeer C.; Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial. Thromb Haemost 2015,113(5),1135-1144","journal-title":"Thromb Haemost"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1007\/s11255-019-02275-2","volume":"51","author":"Oikonomaki T.","year":"2019","unstructured":"Oikonomaki T.; Papasotiriou M.; Ntrinias T.; The effect of vitamin K2 supplementation on vascular calcification in haemodialysis patients: A 1-year follow-up randomized trial. Int Urol Nephrol 2019,51(11),2037-2044","journal-title":"Int Urol Nephrol"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/ckj\/sfab017","volume":"14","author":"Levy-Schousboe K.","year":"2021","unstructured":"Levy-Schousboe K.; Frimodt-M\u00f8ller M.; Hansen D.; Vitamin K supplementation and arterial calcification in dialysis: Results of the double-blind, randomised, placebo-controlled renakvit trial. Clin Kidney J 2021,14(9),2114-3","journal-title":"Clin Kidney J"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12882-017-0560-3","volume":"18","author":"Neradova A.","year":"2017","unstructured":"Neradova A.; Schumacher S.P.; Hubeek I.; Lux P.; Schurgers L.J.; Vervloet M.G.; Phosphate binders affect vitamin K concentration by undesired binding, an in vitro study. BMC Nephrol 2017,18(1),149","journal-title":"BMC Nephrol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1681\/ASN.2019060579","volume":"31","author":"De Vriese A.S.","year":"2020","unstructured":"De Vriese A.S.; Caluw\u00e9 R.; Pyfferoen L.; Multicenter randomized controlled trial of vitamin K antagonist replacement by rivaroxaban with or without vitamin K2 in hemodialysis patients with atrial fibrillation: The Valkyrie Study. J Am Soc Nephrol 2020,31(1),186-196","journal-title":"J Am Soc Nephrol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fmed.2020.00154","volume":"7","author":"Roumeliotis S.","year":"2020","unstructured":"Roumeliotis S.; Dounousi E.; Salmas M.; Eleftheriadis T.; Liakopoulos V.; Vascular calcification in chronic kidney disease: The role of vitamin K- dependent matrix Gla protein. Front Med (Lausanne) 2020,7,154","journal-title":"Front Med (Lausanne)"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"e001070","DOI":"10.1136\/openhrt-2019-001070","volume":"7","author":"Lees J.S.","year":"2020","unstructured":"Lees J.S.; Mangion K.; Rutherford E.; Vitamin K for kidney transplant organ recipients: investigating vessel stiffness (ViKTORIES): Study rationale and protocol of a randomised controlled trial. Open Heart 2020,7(2),e001070","journal-title":"Open Heart"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40697-015-0053-x","volume":"2","author":"Holden R.M.","year":"2015","unstructured":"Holden R.M.; Booth S.L.; Day A.G.; Inhibiting the progression of arterial calcification with vitamin K in HemoDialysis patients (iPACK-HD) trial: Rationale and study design for a randomized trial of vitamin K in patients with end stage kidney disease. Can J Kidney Health Dis 2015,2(1),17","journal-title":"Can J Kidney Health Dis"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/ndt\/gft459","volume":"29","author":"Krueger T.","year":"2014","unstructured":"Krueger T.; Schlieper G.; Schurgers L.; Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): A rationale and study protocol. Nephrol Dial Transplant 2014,29(9),1633-1638","journal-title":"Nephrol Dial Transplant"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s00394-020-02469-w","volume":"60","author":"Roumeliotis S.","year":"2021","unstructured":"Roumeliotis S.; Roumeliotis A.; Eleftheriadis T.; Liakopoulos V.; Letter to the Editor regarding \u201cSix months vitamin K treatment does not affect systemic arterial calcification or bone mineral density in diabetes mellitus 2\u201d. Eur J Nutr 2021,60(3),1701-1702","journal-title":"Eur J Nutr"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2174\/1570161118666200317151553","volume":"19","year":"2021","unstructured":"Could antioxidant supplementation delay progression of cardiovascular disease in end-stage renal disease patients? Curr Vasc Pharmacol Roumeliotis S, Roumeliotis A, Gorny X, Mertens PR2021,19(1),41-54","journal-title":"Curr Vasc Pharmacol"}],"container-title":["Current Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570161120666220209145341","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/200979\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570161120666220209145341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T18:30:59Z","timestamp":1691865059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/200979\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570161120666220209145341","relation":{},"ISSN":["1570-1611"],"issn-type":[{"value":"1570-1611","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-11-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}